This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Anthera Pharmaceuticals Inc (ANTH)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 25.95M 19.43M 65.62M 40.03M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 50.00K 0.00 0.00
Total Current Assets 26.30M 25.18M 67.98M 65.25M
Property, Plant & Equipment, Gross 1.63M 1.61M 1.41M 104.85K
Accumulated Depreciation & Depletion 816.00K 463.00K 132.00K 87.56K
Property, Plant & Equipment, Net 812.00K 1.15M 1.28M 17.28K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 10.30M 116.00K 240.00K 0.00
Total Non-Current Assets 11.11M 1.27M 1.52M 17.28K
Liabilities & Shareholder Equity
Total Assets 37.42M 26.44M 69.49M 65.26M
Accounts Payable 3.52M 5.21M 17.43M 3.79M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 7.56M 18.75M 30.24M 8.01M
Long Term Debt 15.10M 11.22M 20.17M 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 15.10M 11.22M 20.17M 0.00
Total Liabilities 22.66M 29.97M 50.41M 8.01M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 14.76M -3.53M 19.08M 57.26M
Common Par 19.00K 79.00K 41.00K 32.85K
Additional Paid In Capital 301.95M 256.79M 220.05M 162.92M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -287.21M -260.38M -200.98M -105.64M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 -17.00K -29.00K -50.62K
Total Capitalization 29.86M 7.70M 39.26M 57.26M
Total Equity 14.76M -3.53M 19.08M 57.26M
Total Liabilities & Stock Equity 37.42M 26.44M 69.49M 65.26M
Total Common Shares Outstanding 19.42M 9.89M 5.12M 4.11M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 18.27M 7.23M 4.68M 2.86M
Diluted Weighted Shares Outstanding 18.27M 7.23M 4.68M 2.86M
Number of Employees 25 23 38 25
Number of Part-Time Employees 0 0 0 0
ANTH News

ANTH Anthera Pharmaceuticals Inc

Analysts Ratings for ANTH

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ANTH ANALYST REPORT

Brokerage Partners

ANTH Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs